For the early stage RCC, we found that high expression levels of CXCL13 and STAT1 resulted in poor DFS while the high expression levels of IDO1, CXCL13 and GZMB were related to detrimental OS. This evidence concerns the gene CXCL13 and renal cell carcinoma.